Delivery Order SPE2DB22D3501-SPE2DB25FVM01

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,713.47 firm-fixed-price contract is for the delivery of 250 milliliter bottles of the anesthesia drug Ultane. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.25 firm fixed-price contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has a period of performance through November 13, 2024 and is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.44 firm fixed-price contract is for the delivery of 250 ML ULTANE Pen Bottles, a pharmaceutical product. The contract has a period of performance through March 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.12, is for the supply of Ultane 250 ML Pen Bottles, a medical product used in healthcare settings. The contract is a Firm Fixed Price arrangement, without any set-aside designation, and has a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,778.60 firm fixed price delivery order (Contract #SPE2DB20D1100|SPE2DB24FA8G4) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 250 ml bottles of the pharmaceutical product ULTANE. This delivery order is part of a larger indefinite delivery contract (IDC) potentially valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products and has a performance period through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product, valued at $1,675.53. The contract has a firm fixed price pricing type and a completion date of November 27, 2024. It was awarded on November 26, 2024 and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,887.80 firm fixed-price contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML products, with a potential value of $3,027.66 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ultane 250 ML Pen Bottle 250ML. The contract has a ceiling value of $2,778.60 and a period of performance through April 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVM01
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,732.68, is for the supply of 250 ml bottles of the anesthetic drug Ultane. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/29/25, 9:56 AM